Literature DB >> 24575547

Acr appropriateness Criteria management of vaginal cancer.

Larissa J Lee1, Anuja Jhingran2, Elizabeth Kidd3, Higinia Rosa Cardenes4, Mohamed A Elshaikh5, Beth Erickson6, Nina A Mayr7, David Moore8, Ajmel A Puthawala9, Gautam G Rao10, William Small11, Mahesh A Varia12, Andrew O Wahl13, Aaron H Wolfson14, Catheryn M Yashar15, William Yuh16, David K Gaffney17.   

Abstract

Due to its rarity, treatment guidelines for vaginal cancer are extrapolated from institutional reports and prospective studies of cervical and anal cancer. An expert panel was convened to reach consensus on the selection of imaging and therapeutic modalities. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) used by the panel to rate the appropriateness of imaging and treatment procedures. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Four variants were developed to represent clinical scenarios in vaginal cancer management. Group members reached consensus on the appropriateness of the pretreatment evaluation and therapeutic interventions. This article represents the consensus opinion of an expert panel and may be used to inform clinical recommendations in vaginal cancer management.

Entities:  

Mesh:

Year:  2013        PMID: 24575547

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  5 in total

1.  Formal consensus method to evaluate the conformity of prescription of a recently approved chemotherapy treatment in an observatory study.

Authors:  Nadine Houédé; Eric Leutenegger; Mariella Lomma; Carine Bellera
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

2.  Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review.

Authors:  Shari Damast; Vinita Takiar; Shirley McCarthy; Susan A Higgins
Journal:  Gynecol Oncol Rep       Date:  2016-08-04

3.  Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy- case report and literature review.

Authors:  Jawaher Ansari; Yussra Eltigani Mohmmed; Saad Ghazal-Aswad; Hidayath Ansari; Syed M J Akhter; Omar Hassoun Hadid; Syed Rizwan; Raya Almazrouei; Emad Dawoud; Fathi Azribi; Heba Elhasin; Pawan Kumar; Abdul Rahman Al Sumaida; Khaled Al-Qawasmeh; John Glaholm; M J Hochmair; Syed Hussain; Khalid Balaraj
Journal:  Gynecol Oncol Rep       Date:  2021-10-08

4.  Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12-09).

Authors:  Ji Hyun Chang; Won Il Jang; Yong Bae Kim; Jin Hee Kim; Young Seok Kim; Yeon Sil Kim; Won Park; Juree Kim; Won Sup Yoon; Joo-Young Kim; Hak Jae Kim
Journal:  J Gynecol Oncol       Date:  2016-03       Impact factor: 4.401

5.  Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

Authors:  Toshiaki Saito; Tsutomu Tabata; Hitoshi Ikushima; Hiroyuki Yanai; Hironori Tashiro; Hitoshi Niikura; Takeo Minaguchi; Toshinari Muramatsu; Tsukasa Baba; Wataru Yamagami; Kazuya Ariyoshi; Kimio Ushijima; Mikio Mikami; Satoru Nagase; Masanori Kaneuchi; Nobuo Yaegashi; Yasuhiro Udagawa; Hidetaka Katabuchi
Journal:  Int J Clin Oncol       Date:  2017-11-20       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.